Bacterial Infection in Ebola Virus Disease, Marburg Virus Disease, Crimean-Congo Hemorrhagic Fever, and Lassa Fever
Abstract
Background: Concern for bacterial coinfection in patients with high consequence viral infections (HCVIs) has made empiric antibiotic administration the standard of care. However, the incidence, microbiology, and clinical significance of bacterial coinfection in HCVIs remain unclear.
Methods: We conducted a systematic review of case reports, cohort studies, and cross-sectional analyses describing bacterial coinfection in Ebola virus disease (EVD), Marburg virus disease (MVD), Crimean-Congo hemorrhagic fever (CCHF), and Lassa fever (LF). Data were extracted on study design, setting, diagnostic methods, pathogens, antibiotic use, and outcomes.
Results: Thirty publications met inclusion criteria. Bacteremia was most commonly reported among patients with CCHF (n = 46), followed by EVD (n = 16), MVD (n = 16), and LF (n = 2). Of 27 EVD patients treated outside Africa, 7 (26%) had bacterial coinfection. Across HCVIs, bacteremia was detected a median of 11 days after symptom onset (range 0-23) and was associated with features of sepsis. Pathogens included enteric flora, healthcare-associated organisms, opportunistic pathogens, and zoonotic bacteria-most notably Brucella spp. in CCHF. Ceftriaxone was the most common empiric antibiotic but is predicted to have activity against a minority of bloodstream isolates. Mortality among coinfected patients with EVD or MVD was similar to those without bacterial coinfection, whereas coinfected CCHF patients had higher mortality than those without…
Read the paper
Related studies
- Horizontal gene transfer in the human gastrointestinal tract: potential spread of antibiotic resistance genes
- Mutation supply and relative fitness shape the genotypes of ciprofloxacin-resistant Escherichia coli
- Genomic Survey of E. coli From the Bladders of Women With and Without Lower Urinary Tract Symptoms
- Characterization of cefotaxime-resistant urinary Escherichia coli from primary care in South-West England 2017–18
- Fitness cost constrains the spectrum of marR mutations in ciprofloxacin-resistant Escherichia coli
- Emerging evidence-based innovative approaches to control catheter-associated urinary tract infection: a review
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.